Search Medical Condition
Please enter condition
Please choose location from dropdown

Tlapan, Mexico Clinical Trials

A listing of Tlapan, Mexico clinical trials actively recruiting patients volunteers.

RESULTS

Found (247) clinical trials

Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis Compared to Gatifloxacin 0.3%.

The study subjects will be recruited from various research centers in western and central Mexico. Each research center has a monitoring plan specified according to the recruitment capabilities of the same, which must be at least once a month, where the queries of your data entered into the electronic case ...

Phase

2.61 miles

Learn More »

A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

The main purpose of this study is to compare how long subjects with esophageal cancer live overall or live without disease progression after receiving nivolumab and ipilimumab or nivolumab combined with fluorouracil plus cisplatin versus fluorouracil plus cisplatin

Phase

2.73 miles

Learn More »

Effect of the CAIPaDi Care Model in Relatives of Patients With Type 2 Diabetes Mellitus

Diabetes mellitus is one of the most challenging health issues of our time, the percentage of adults with this disease tripled in Mexico between 1993 and 2012; In 1993 the prevalence was 6.7% (cases previously diagnosed 4.6% and diagnosed during the survey 2.1%), whereas in 2012, the prevalence was 14.4% ...

Phase N/A

2.73 miles

Learn More »

Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis

Oxidative stress is produced by imbalance between reactive oxygen species and antioxidant systems. This state is frequently associated with chronic diseases like obesity, insulin resistance, metabolic syndrome and hepatic steatosis. In the liver, the oxidative stress may trigger the progression of fatty liver disease, from triglyceride accumulation to inflammation, cirrhosis ...

Phase

2.73 miles

Learn More »

A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer

This study will evaluate the efficacy, safety, and pharmacokinetics of adjuvant atezolizumab in combination with paclitaxel, followed by atezolizumab, dose-dense doxorubicin or epirubicin (investigator's choice), and cyclophosphamide, compared with paclitaxel followed by dose-dense doxorubicin or epirubicin (investigator's choice) and cyclophosphamide alone in patients with Stage II-III TNBC (Triple Negative Breast ...

Phase

2.73 miles

Learn More »

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

A 52-week study to compare the efficacy of relamorelin with that of placebo in participants with diabetic gastroparesis (DG) with respect to the core signs and symptoms of diabetic gastroparesis.

Phase

2.73 miles

Learn More »

Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography

Endoscopic retrograde cholangiopancreatography (ERCP) complications occur in 5 to 10% of cases, post ERCP pancreatitis is the most common, it is a complication with significant morbidity, occasional mortality and high costs. In the prevention of post-ERCP pancreatitis have been used various treatments, NSAIDs and pancreatic stent are the most useful, ...

Phase N/A

2.73 miles

Learn More »

Evaluation of Intestinal Permeability Expression of Genes of Epithelial Integrity in the Duodenal Wall Serum Inflammatory Cytokines and Lipopolysaccharide in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

There is evidence that the non-selective beta-blocker (NSBB) propranolol reduces intestinal permeability and decreases bacterial translocation in cirrhotic patients, independent of hemodynamic effects on portal pressure. The mechanism by which this decrease in intestinal permeability and bacterial translocation occurs has not been established. Among the proposed mechanisms are: modification of ...

Phase N/A

2.73 miles

Learn More »

Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders

There are case reports and pilot studies in patients with primary biliary cholangitis (PBC) In the literature in which the effect of fibrates (specially bezafibrate) on the improvement of biochemical cholestasis have been seen, however the clinical benefit (survival, mortality, fatigue, pruritus) has not been reported and likewise the response ...

Phase

2.73 miles

Learn More »

Efficacy and Safety of the Implementation of an Algorithm for Enteral Nutrition Support.

The algorithms for the enteral nutrition support also called protocols had been developed and implemented in the intensive care units (ICU) across the world to enhance the provision of calories and proteins via enteral nutrition (EN), increasing the proportion of patients that received an optimal amount (80-85% of their energy ...

Phase N/A

2.73 miles

Learn More »